CRVS
CorvusDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
CRVS vs peer average
36/100
CRVS vs. peer average (D vs. C)
Grade spread
A 1 · B 4 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANRO is the first available peer comparator.
Small-cap clinical-stage biotech with similar market-cap and financing sensitivity, but not a close indication match; useful mainly for risk-appetite and capital-markets comparison.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CRVS
Corvus
ANRO
Alto Neuroscience
Grade
D
B
Momentum
10
61
Value
41
41
Sentiment
83
83
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ANRO
CRVS / ANRO
Grade Position
Below peers
CRVS vs. peer average (D vs. C)
36/100
Momentum
10
ANROValue
41
CRVSSentiment
83
CRVSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CRVS
ANRO is the first peer returned for this comparison set.